NPM1 mutation is not associated with prolonged complete remission in acute myeloid leukemia patients treated with hypomethylating agents

MeSH terms

• Aged
• Aged, 80 and over
• Antineoplastic Agents
• Disease-Free Survival
• Female
• Humans
• Leukemia, Myeloid, Acute* / drug therapy
• Leukemia, Myeloid, Acute* / genetics
• Leukemia, Myeloid, Acute* / mortality
• Male
• Middle Aged
• Mutation*
• Neoplasm Proteins / administration & dosage*
• Nuclear Proteins / genetics*
• Nucleophosmin
• Remission Induction
• Retrospective Studies
• Survival Rate